You are here

UNIVERSAL STABILIZATION TECHNOLOGIES, INC.

Company Information
Address
4050 SORRENTO VALLEY BLVD STE L
SAN DIEGO, CA 92121-1425
United States



Information

UEI: M7VASTVN1J49

# of Employees: 8


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Thermostable Inactivated Potent Yellow Fever Vaccine

    Amount: $596,270.00

    SummaryYellow Fever (YF) is an acute viral hemorrhagic fever disease caused by Yellow Fevervirus (YFV) and an estimated 200,000 YF infections occur annually. Approximately 50% ofinfected individuals t ...

    STTRPhase I2021Department of Health and Human Services National Institutes of Health
  2. Development of a thermostable, electron beam inactivated Sabin-based polio vaccine for mucosal delivery

    Amount: $221,743.00

    Project Summary AbstractInactivated Polio VaccineIPVand Oral Polio VaccineOPVmanufactured today are both unstable at high ambient temperaturesi eCand require maintenance of a cold chain to prevent pot ...

    SBIRPhase I2018Department of Health and Human Services Centers for Disease Control and Prevention
  3. Adjuvant Development for a Thermostable Respiratory Influenza Vaccine

    Amount: $599,749.00

    The objective of the proposed project is evaluation of two novel non aluminum vaccine adjuvantsCpG ODN and AdVaxinulin polysaccharidewith intranasal delivery of thermostable live attenuated influenza ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  4. Development of a thermostable rotavirus vaccine for mucosal delivery withoutneed for reconstitution- Phase II

    Amount: $1,270,617.00

    PROJECT SUMMARY ABSTRACTRotavirusRVis responsible for an estimateddeaths each year from severe diarrheamostly in children in developing countriesCurrently only two RV vaccines are broadly availableand ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  5. Thermostable Live Attenuated Influenza Vaccine for Nasal Delivery

    Amount: $999,938.00

    Problems exist with current influenza vaccines because of the need for refrigeration virus shedding professionals required for injection or liquid nasal administration and slow egg based productio ...

    SBIRPhase II2017Department of Health and Human Services Centers for Disease Control and Prevention
  6. Thermostable Respiratory

    Amount: $149,863.00

    Ongoing disease and death associated with influenza infection are high priority issues for global public health Current Influenza vaccines require refrigeration which is difficult to manage in devel ...

    SBIRPhase I2016Department of Health and Human Services Centers for Disease Control and Prevention
  7. Development of a thermostable rotavirus vaccine for mucosal delivery without need for reconstitution

    Amount: $147,981.00

    DESCRIPTION provided by applicant Rotavirus is the leading cause of severe dehydrating diarrhea in children worldwide and is responsible for an estimated deaths each year mostly in child ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  8. Tablets for Sublingual Delivery of Measles Vaccines

    Amount: $150,000.00

    Each day, 380 children die from measles virus mostly in developing countries because of the high cost and limited access to vaccines. To address this challenge, a vaccine for measles that is inexpensi ...

    SBIRPhase I2013Department of Health and Human Services Centers for Disease Control and Prevention
  9. Thermostable Measles-Rublella Vaccines for Respiratory Delivery

    Amount: $464,380.00

    WHO estimates that each day, 380 children die from measles and 300 children get birth defects from congenital rubella syndrome, while an unknown number die in utero from rubella, mostly in developing ...

    SBIRPhase II2012Department of Health and Human Services Centers for Disease Control and Prevention
  10. Formulation of Ambient Temperature and Humidity Stable Rabies Vaccines for Oral D

    Amount: $1,145,800.00

    DESCRIPTION (provided by applicant): Rabies is a deadly disease, estimated to cause 40-70 thousand deaths per year. It is most often spread by a bite and saliva from an infected wild or feral animal ...

    SBIRPhase II2010Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government